Dan Olsson

Director/Board Member chez INTEGRATED DIAGNOSTICS HOLDINGS PLC Fortune : 47 697 $ au 31/03/2024

Profil

Dan Olsson is currently the Chief Executive Officer at Neron HSU AB.
He is also the Director at IDL Biotech AB, Independent Non-Executive Director at Integrated Diagnostics Holdings Plc, Director at Svenska Labex AB, and Director at Ambea AB.
Previously, he served as the Chief Executive Officer at Unilabs Group Ltd.
and Unilabs SA from 2007 to 2009.
He was also the Chief Executive Officer at Unilabs AB.
From 2015 to 2019, he held the position of President & Chief Executive Officer at Team Olivia AB.
Prior to that, he was the Chief Executive Officer at Feelgood Företagshälsovård Södra AB from 2011 to 2015.
He has also held positions such as Chairman at Nämndemansgården i Sverige AB, Director at Hedera Group AB, and Manager-Diagnostics Business Area at Capio Närsjukvård AB.
Mr. Olsson completed his undergraduate degree at the University of Lund.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
AMBEA AB 0,01%	22/11/2023	8 000 ( 0,01% )	47 697 $	31/03/2024

Postes actifs de Dan Olsson

Sociétés	Poste	Début
INTEGRATED DIAGNOSTICS HOLDINGS PLC	Director/Board Member	12/01/2015
IDL BIOTECH AB	Director/Board Member	01/01/2020
AMBEA AB	Director/Board Member	01/01/2022
Neron HSU AB	Chief Executive Officer	-
Svenska Labex AB	Director/Board Member	01/06/2019

Anciens postes connus de Dan Olsson

Sociétés	Poste	Fin
Team Olivia AB	Chief Executive Officer	06/02/2019
Feelgood Företagshälsovård Södra AB	Chief Executive Officer	01/03/2015
Unilabs SA	Chief Executive Officer	01/05/2009
Unilabs Group Ltd.	Chief Executive Officer	01/01/2009
░░░░░ ░░	░░░░░ ░░░░░░░░░ ░░░░░░░	-

Formation de Dan Olsson

University of Lund

Undergraduate Degree